BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 16604718)

  • 1. Analysis of induced radionuclides in low-activation concrete (limestone concrete) using the 12 GeV proton synchrotron accelerator facility at KEK.
    Saito K; Tanosaki T; Fujii H; Miura T
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):647-52. PubMed ID: 16604718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement and analysis of induced activities in concrete irradiated using high-energy neutrons at KENS Neutron Spallation Source Facility.
    Oishi K; Nakao N; Kosako K; Yamakawa H; Nakashima H; Kawai M; Yashima H; Sanami T; Numajiri M; Shibata T; Hirayama H; Nakamura T
    Radiat Prot Dosimetry; 2005; 115(1-4):623-9. PubMed ID: 16381795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calculations of neutron shielding data for 10-100 MeV proton accelerators.
    Chen CC; Sheu RJ; Jian SH
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):245-51. PubMed ID: 16604637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the radioactivity of the pre-dominant gamma emitters in components used at high-energy proton accelerator facilities.
    Numajiri M
    Radiat Prot Dosimetry; 2007; 123(4):417-25. PubMed ID: 17164270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arrangement of high-energy neutron irradiation field and shielding experiment using 4 m concrete at KENS.
    Nakao N; Yashima H; Kawai M; Oishi K; Nakashima H; Masumoto K; Matsumura H; Sasaki S; Numajiri M; Sanami T; Wang Q; Toyoda A; Takahashi K; Iijima K; Eda K; Ban S; Hirayama H; Muto S; Nunomiya T; Yonai S; Rasolonjatovo DR; Terunuma K; Yamauchi K; Sarkar PK; Kim E; Nakamura T; Maruhashi A
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):553-7. PubMed ID: 16604697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurements of neutron effective doses and attenuation lengths for shielding materials at the heavy-ion medical accelerator in Chiba.
    Kumamoto Y; Noda Y; Sato Y; Kanai T; Murakami T
    Health Phys; 2005 May; 88(5):469-79. PubMed ID: 15824595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 12B counter: an active dosemeter for high-energy neutrons.
    Leuschner A
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):144-7. PubMed ID: 16604616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mars14 Monte Carlo simulation for the shielding studies of the J-PARC 3 GeV ring.
    Nakao N; Mokhov N; Yamamoto K; Irie Y; Drozhdin A
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):85-8. PubMed ID: 16604603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induced radioactivities in concrete constituents irradiated by high-energy particles.
    Kondo K; Hirayama H; Ban S; Taino M; Ishii H
    Health Phys; 1984 Jun; 46(6):1221-39. PubMed ID: 6724935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced radioactivity in the forward shielding and semiconductor tracker of the ATLAS detector.
    Bĕdajánek I; Linhart V; Stekl I; Pospísil S; Kolros A; Kovalenko V
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):16-8. PubMed ID: 16604587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation streaming experiment through a labyrinth of the 12 GeV proton accelerator facility at KEK(2)--TLD REM-counter method.
    Nakamura H; Miura T; Numajiri M; Nakao N; Nakashima H; Matsuda N; Watanabe S
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):252-5. PubMed ID: 16604638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benchmark studies of induced radioactivity produced in LHC materials, Part II: Remanent dose rates.
    Brugger M; Khater H; Mayer S; Prinz A; Roesler S; Ulrici L; Vincke H
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):12-5. PubMed ID: 16604586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shielding analysis at the upper section of the accelerator-driven system.
    Sasa T; Yang JA; Oigawa H
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):256-8. PubMed ID: 16604639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benchmark studies of induced radioactivity produced in LHC materials, Part I: Specific activities.
    Brugger M; Khater H; Mayer S; Prinz A; Roesler S; Ulrici L; Vincke H
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):6-11. PubMed ID: 16604585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and radiation protection studies for the W-Ta target of CSNS.
    Yu QZ; Liang TJ; Yin W
    Radiat Prot Dosimetry; 2009 Sep; 136(3):216-21. PubMed ID: 19770213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of radiation fields outside the Sub-critical Assembly in Dubna.
    Seltbor P; Lopatkin A; Gudowski W; Shvetsov V; Polanski A
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):449-53. PubMed ID: 16604676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation analysis of concrete and graphite in the experimental reactor RUS.
    Cometto M; Ridikas D; Aubert MC; Damoy F; Ancius D
    Radiat Prot Dosimetry; 2005; 115(1-4):104-9. PubMed ID: 16381692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of high-energy neutrons estimated using the radioactive spallation products of Au at the 500-MeV neutron irradiation facility of KENS.
    Matsumura H; Masumoto K; Nakao N; Wang Q; Toyoda A; Kawai M; Aze T; Fujimura M
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):1-5. PubMed ID: 16604584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the neutron beam line shield design for JSNS.
    Kawai M; Saito K; Sanami T; Nakao N; Maekawa F
    Radiat Prot Dosimetry; 2005; 115(1-4):580-6. PubMed ID: 16381789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of secondary neutron production relevant to shielding in space.
    Heilbronn L; Nakamura T; Iwata Y; Kurosawa T; Iwase H; Townsend LW
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):140-3. PubMed ID: 16604615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.